ABSCI CORP Operating Lease Liability
ABSCI CORP (ABSI) had Operating Lease Liability of $4.43 million as of 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-24
- 2025-12-31: Operating Lease, Liability $4.43M.
- 2024-12-31: Operating Lease, Liability $6.04M.
- 2023-12-31: Operating Lease, Liability $7.32M.
- 2022-12-31: Operating Lease, Liability $9.01M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $4.43M 10-K · filed 2026-03-24 |
| 2024-12-31 | $6.04M 10-K · filed 2025-03-18 |
| 2023-12-31 | $7.32M 10-K · filed 2024-03-21 |
| 2022-12-31 | $9.01M 10-K · filed 2023-03-30 |
| 2021-12-31 | $10.47M 10-K · filed 2022-03-22 |
| 2021-09-30 | $10.82M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $10.40M 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |